Center-Authored Papers

Filters: Author is Reed, Shelby D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Dinan MA, Mi X, Reed SD, Hirsch BR, Lyman GH, Curtis LH.  2015.  Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.. JAMA oncology. 1(2):158-66. Abstract
Dinan MA, Mi X, Reed SD, Lyman GH, Curtis LH.  2015.  Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.. JAMA oncology. Abstract
R
Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD.  2015.  Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 18(2):161-72. Abstract
Ramsey SD, Malin JL, Goulart B, Ambrose LF, Kanne JP, McKee AB, Reed SD, Schwartz SJ, Sullivan SD.  2015.  Implementing Lung Cancer Screening Using Low-Dose Computed Tomography: Recommendations From an Expert Panel.. Journal of oncology practice / American Society of Clinical Oncology. 11(1):e44-9. Abstract
Ramsey SD, Sullivan SD, Reed SD, Tina Shih Y-C, Schaecher K, Dhanda R, Patt D, Pendergrass K, Walker M, Malin J et al..  2013.  Oncology Comparative Effectiveness Research: A Multistakeholder Perspective on Principles for Conduct and Reporting.. The oncologist. Abstract
Reed SD, Dinan MA, Schulman KA, Lyman GH.  2013.  Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer.. Genetics in medicine : official journal of the American College of Medical Genetics. 15(3):203-11. Abstract
Reed SD, Lyman GH.  2012.  Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.. Cancer. 118(24):6298-9;authorreply6299-300.